Logo image of IR

INGERSOLL-RAND INC (IR) Stock Fundamental Analysis

NYSE:IR - New York Stock Exchange, Inc. - US45687V1061 - Common Stock

94.08  +2.2 (+2.39%)

After market: 94.08 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to IR. IR was compared to 131 industry peers in the Machinery industry. While IR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. IR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IR was profitable.
In the past year IR had a positive cash flow from operations.
IR had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IR had a positive operating cash flow.
IR Yearly Net Income VS EBIT VS OCF VS FCFIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

1.2 Ratios

With a Return On Assets value of 4.61%, IR perfoms like the industry average, outperforming 55.12% of the companies in the same industry.
IR has a Return On Equity (8.17%) which is in line with its industry peers.
The Return On Invested Capital of IR (6.79%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IR is significantly below the industry average of 11.19%.
The 3 year average ROIC (5.30%) for IR is below the current ROIC(6.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.61%
ROE 8.17%
ROIC 6.79%
ROA(3y)4.27%
ROA(5y)3.21%
ROE(3y)6.93%
ROE(5y)5.79%
ROIC(3y)5.3%
ROIC(5y)4.48%
IR Yearly ROA, ROE, ROICIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin of IR (11.72%) is better than 81.10% of its industry peers.
IR's Profit Margin has improved in the last couple of years.
IR's Operating Margin of 19.90% is amongst the best of the industry. IR outperforms 87.40% of its industry peers.
IR's Operating Margin has been stable in the last couple of years.
IR has a Gross Margin of 43.81%. This is amongst the best in the industry. IR outperforms 80.31% of its industry peers.
IR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.9%
PM (TTM) 11.72%
GM 43.81%
OM growth 3Y37.76%
OM growth 5Y1.4%
PM growth 3YN/A
PM growth 5Y2.49%
GM growth 3Y5.83%
GM growth 5Y2.17%
IR Yearly Profit, Operating, Gross MarginsIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

6

2. Health

2.1 Basic Checks

IR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IR has been reduced compared to 1 year ago.
Compared to 5 years ago, IR has more shares outstanding
The debt/assets ratio for IR has been reduced compared to a year ago.
IR Yearly Shares OutstandingIR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
IR Yearly Total Debt VS Total AssetsIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

IR has an Altman-Z score of 3.85. This indicates that IR is financially healthy and has little risk of bankruptcy at the moment.
IR's Altman-Z score of 3.85 is in line compared to the rest of the industry. IR outperforms 58.27% of its industry peers.
The Debt to FCF ratio of IR is 3.66, which is a good value as it means it would take IR, 3.66 years of fcf income to pay off all of its debts.
IR has a Debt to FCF ratio (3.66) which is in line with its industry peers.
IR has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IR (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.66
Altman-Z 3.85
ROIC/WACC0.72
WACC9.48%
IR Yearly LT Debt VS Equity VS FCFIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.3 Liquidity

IR has a Current Ratio of 2.36. This indicates that IR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IR (2.36) is better than 60.63% of its industry peers.
IR has a Quick Ratio of 1.71. This is a normal value and indicates that IR is financially healthy and should not expect problems in meeting its short term obligations.
IR has a better Quick ratio (1.71) than 72.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 1.71
IR Yearly Current Assets VS Current LiabilitesIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

6

3. Growth

3.1 Past

IR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.38%, which is quite good.
The Earnings Per Share has been growing by 9.50% on average over the past years. This is quite good.
IR shows a small growth in Revenue. In the last year, the Revenue has grown by 7.18%.
IR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.65% yearly.
EPS 1Y (TTM)17.38%
EPS 3Y25.15%
EPS 5Y9.5%
EPS Q2Q%9.09%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y20.06%
Revenue growth 5Y20.65%
Sales Q2Q%7.02%

3.2 Future

Based on estimates for the next years, IR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.42% on average per year.
IR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.26% yearly.
EPS Next Y15.2%
EPS Next 2Y11.05%
EPS Next 3Y10.75%
EPS Next 5Y11.42%
Revenue Next Year6.27%
Revenue Next 2Y6.31%
Revenue Next 3Y6.19%
Revenue Next 5Y7.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IR Yearly Revenue VS EstimatesIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
IR Yearly EPS VS EstimatesIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.42, which means the current valuation is very expensive for IR.
IR's Price/Earnings ratio is in line with the industry average.
IR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 25.77, IR can be considered very expensive at the moment.
IR's Price/Forward Earnings ratio is in line with the industry average.
IR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 28.42
Fwd PE 25.77
IR Price Earnings VS Forward Price EarningsIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

64.57% of the companies in the same industry are cheaper than IR, based on the Enterprise Value to EBITDA ratio.
IR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 28.98
EV/EBITDA 21.75
IR Per share dataIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IR does not grow enough to justify the current Price/Earnings ratio.
IR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.87
PEG (5Y)2.99
EPS Next 2Y11.05%
EPS Next 3Y10.75%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.09%, IR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.65, IR has a dividend in line with its industry peers.
With a Dividend Yield of 0.09, IR pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.09%

5.2 History

IR has paid a dividend for at least 10 years, which is a reliable track record.
IR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
IR Yearly Dividends per shareIR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

IR pays out 3.85% of its income as dividend. This is a sustainable payout ratio.
DP3.85%
EPS Next 2Y11.05%
EPS Next 3Y10.75%
IR Yearly Income VS Free CF VS DividendIR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B
IR Dividend Payout.IR Dividend Payout, showing the Payout Ratio.IR Dividend Payout.PayoutRetained Earnings

INGERSOLL-RAND INC

NYSE:IR (1/21/2025, 8:08:02 PM)

After market: 94.08 0 (0%)

94.08

+2.2 (+2.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)02-13 2025-02-13/amc
Inst Owners100.1%
Inst Owner Change-0.04%
Ins Owners0.18%
Ins Owner Change-0.61%
Market Cap37.92B
Analysts76.8
Price Target113.16 (20.28%)
Short Float %2.18%
Short Ratio4.14
Dividend
Industry RankSector Rank
Dividend Yield 0.09%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP3.85%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.65%
Min EPS beat(2)0.25%
Max EPS beat(2)3.04%
EPS beat(4)4
Avg EPS beat(4)5.36%
Min EPS beat(4)0.25%
Max EPS beat(4)9.69%
EPS beat(8)8
Avg EPS beat(8)9.11%
EPS beat(12)12
Avg EPS beat(12)7.7%
EPS beat(16)16
Avg EPS beat(16)9.79%
Revenue beat(2)0
Avg Revenue beat(2)-3.13%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-2.68%
Revenue beat(4)0
Avg Revenue beat(4)-2.86%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)-0.58%
Revenue beat(8)4
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)0.11%
Revenue beat(16)9
Avg Revenue beat(16)-1.94%
PT rev (1m)0.63%
PT rev (3m)8.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 28.42
Fwd PE 25.77
P/S 5.3
P/FCF 28.98
P/OCF 26.11
P/B 3.69
P/tB N/A
EV/EBITDA 21.75
EPS(TTM)3.31
EY3.52%
EPS(NY)3.65
Fwd EY3.88%
FCF(TTM)3.25
FCFY3.45%
OCF(TTM)3.6
OCFY3.83%
SpS17.76
BVpS25.48
TBVpS-5.92
PEG (NY)1.87
PEG (5Y)2.99
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 8.17%
ROCE 8.67%
ROIC 6.79%
ROICexc 7.41%
ROICexgc 46.42%
OM 19.9%
PM (TTM) 11.72%
GM 43.81%
FCFM 18.28%
ROA(3y)4.27%
ROA(5y)3.21%
ROE(3y)6.93%
ROE(5y)5.79%
ROIC(3y)5.3%
ROIC(5y)4.48%
ROICexc(3y)6.07%
ROICexc(5y)5.13%
ROICexgc(3y)39.03%
ROICexgc(5y)29.9%
ROCE(3y)6.77%
ROCE(5y)5.72%
ROICexcg growth 3Y61.03%
ROICexcg growth 5Y7.63%
ROICexc growth 3Y68.38%
ROICexc growth 5Y-3.69%
OM growth 3Y37.76%
OM growth 5Y1.4%
PM growth 3YN/A
PM growth 5Y2.49%
GM growth 3Y5.83%
GM growth 5Y2.17%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.66
Debt/EBITDA 2.52
Cap/Depr 30.13%
Cap/Sales 2%
Interest Coverage 12.45
Cash Conversion 76.41%
Profit Quality 156.03%
Current Ratio 2.36
Quick Ratio 1.71
Altman-Z 3.85
F-Score6
WACC9.48%
ROIC/WACC0.72
Cap/Depr(3y)20%
Cap/Depr(5y)19.21%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.46%
Profit Quality(3y)129.33%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3Y25.15%
EPS 5Y9.5%
EPS Q2Q%9.09%
EPS Next Y15.2%
EPS Next 2Y11.05%
EPS Next 3Y10.75%
EPS Next 5Y11.42%
Revenue 1Y (TTM)7.18%
Revenue growth 3Y20.06%
Revenue growth 5Y20.65%
Sales Q2Q%7.02%
Revenue Next Year6.27%
Revenue Next 2Y6.31%
Revenue Next 3Y6.19%
Revenue Next 5Y7.26%
EBIT growth 1Y21.24%
EBIT growth 3Y65.39%
EBIT growth 5Y22.34%
EBIT Next Year44.75%
EBIT Next 3Y18.97%
EBIT Next 5Y15.34%
FCF growth 1Y99.22%
FCF growth 3Y13.4%
FCF growth 5Y26.52%
OCF growth 1Y95.99%
OCF growth 3Y14.64%
OCF growth 5Y25.38%